S 297
PSA Screening for HIM Act
Progress
Timeline
- Mar 19Committee on Health, Education, Labor, and Pensions. Hearings held.
Summary
**What it does:** This bill (S 297) would establish or expand screening programs for prostate cancer using PSA (prostate-specific antigen) blood tests. **Who it affects:** - Men, particularly those at higher risk for prostate cancer (typically men over 50, African American men, and those with family history) - Healthcare providers who would offer the screening - Insurance companies that would need to cover the screenings **What would change:** - More standardized availability of PSA screening programs - Potentially increased early detection of prostate cancer - Clearer guidelines for when and how often men should be screened - Possible insurance coverage requirements for these screenings The bill is currently under review in committee, so specific details about funding, implementation timeline, and exact coverage requirements are still being determined. The goal is to improve men's health outcomes through better access to prostate cancer screening.
How This Affects You
Related Bills
Get personalized insights on this bill
CivicRadar tells you exactly how government actions affect your life based on your location, interests, and profession.